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Abstract: In Argentina, hemolytic uremic syndrome (HUS) constitutes the most frequent cause 
of acute renal failure in children. Approximately 2%–4% of patients die during the acute phase, 
and one-third of the 96% who survive are at risk of chronic renal sequelae. Little information 
is available about the direct effect of Shiga toxin type 2 (Stx2) on the onset of proteinuria and 
the evolution of toxin-mediated glomerular or tubular injury. In this work, rats were injected 
intraperitoneally with recombinant Escherichia coli culture supernatant containing Stx2 (sStx2; 
20 µg/kg body weight) to induce HUS. Functional, immunoblotting, and immunohistochemistry 
studies were carried out to determine alterations in slit diaphragm proteins and the proximal 
tubule endocytic system at 48 hours post-inoculation. We detected a significant increase in 
microalbuminuria, without changes in the proteinuria values compared to the control rats. In 
immunoperoxidase studies, the renal tubules and glomerular mesangium showed an increased 
expression of transforming growth factor β1(TGF-β1). The expression of megalin was decreased 
by immunoperoxidase and the cytoplasm showed a granular pattern of megalin expression by 
immunofluorescence techniques. Western blot analysis performed in the renal cortex from 
sStx2-treated and control rats using anti-nephrin and anti-podocalyxin antibodies showed a 
decreased expression of these proteins. We suggest that the alterations in slit diaphragm proteins 
and megalin expression could be related to the development of microalbuminuria in response 
to lethal doses of Stx2.
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Introduction
In Argentina, hemolytic uremic syndrome (HUS) constitutes the most frequent cause of 
acute renal failure in children. HUS is a disease associated with infection by Shiga toxin 
(Stx)-producing Escherichia coli (STEC), defined by thrombotic microangiopathy, 
hemolytic anemia, thrombocytopenia, and acute renal failure (ARF). Approximately 
2%–4% of patients die during the acute phase, and one-third of the 96% who survive 
are at risk of chronic renal sequelae.1
Although glomerular lesions observed in HUS involve the presence of thrombotic 
microangiopathy, little information is available about the direct effect of Shiga toxin 
type 2 (Stx2) on the onset of proteinuria and the evolution of toxin-mediated glom-
erular injury.
Visceral glomerular epithelial cells or podocytes are currently considered to play an 
important role in the physiology of the glomerular filtration barrier and consequently 
in the pathogenesis of glomerular diseases associated with proteinuria and nephrotic 
syndrome.2
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
29
ORIGINAL RESEARCH
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJNRD.S27623International Journal of Nephrology and Renovascular Disease 2012:5
The foot processes of podocytes are connected by a con-
tinuous membrane-like structure called the slit diaphragm.3
It has been reported that nephrin, a gene product of 
NPHS1, might be a core protein of the slit diaphragm.4 
Although the molecular function of nephrin is still poorly 
understood, recent studies have indicated that nephrin acts as 
a signaling molecule5 and has an intimate relationship with 
filamentous actin.5,6
The external surface of podocytes is covered with a sialic 
acid-rich glycocalyx known as podocalyxin (PC).7 PC is 
the target of injury in many glomerular diseases that affects 
the shape of foot processes and reduces the expression of 
components of the slit diaphragm. One of the consequences 
of the dysfunction of podocytes may be the development of 
albuminuria.
Although albuminuria is an important marker for the 
onset and progression of renal diseases,10 the mechanism by 
which albuminuria is caused still remains a topic of debate. 
Recent studies have investigated the tubular role in the post-
glomerular processing of albumin on the onset of albuminuria 
showing a possible role of TGF-β.11 Recently, evidence has 
suggested that the renal tubular injury observed in HUS is 
also induced by the direct action of Stx2 on tubular epithelial 
cells.12 We have previously reported a model of HUS in rats 
inoculated with lethal doses of Stx2 with alterations similar 
to those described in humans with HUS.13 Recently, we have 
characterized in the same model the early tubular response to 
the effect of Stx2 and detected that tubular cells develop an 
immunophenotype change induced by TGF-β, the first step 
in the evolution of epithelial-to-mesenchymal transition and 
tubule-interstitial fibrosis. Taking into account these results, 
it is feasible that tubular functions are altered, such as protein 
reabsorption. Functional studies in rat kidney suggest that 
megalin15 is involved in albumin endocytosis16 in proximal 
tubules regulated by TGF-β, affecting the level of urinary 
albumin excretion.
Taking all the above into account, the aim of our study 
was to determine the glomerular and tubular response to lethal 
doses of Stx2 in rats. We focused our study on modifications 
of the slit diaphragm and protein tubular endocytosis.
Materials and methods
Adult male Sprague Dawley rats (150 ± 3 g body weight) 
were obtained from the animal facility of the School of 
Pharmacy and Biochemistry, University of Buenos Aires, 
Argentina. The rats were housed individually under con-
trolled conditions of light/dark, humidity, and temperature, 
with food and water available ad libitum.
Experimental protocols
Rats were randomly divided into two groups of six rats each. 
Stx2 injury was induced as previously described.13 Briefly, 
rats from the experimental group (Stx2-treated rats) were 
injected intraperitoneally with recombinant Escherichia coli 
culture supernatant (sStx2) containing Stx2 (LD50: 20 µg/kg 
body weight. The animals died between 48 and 72 hours 
after administration). Control rats were inoculated with 
the same volume of culture supernatant that did not con-
tain Stx2. sStx2 having a cytotoxicity of 2 × 104 CD50/mL 
(1 CD50 = 40 pg/mL) was obtained as previously described.17 
The LPS content in the control and experimental supernatant, 
  determined using the HEK-Blue LPS Detection Kit (In  vitrogen, 
San Diego, CA), was 70 ng LPS/µg Stx2 protein.
Renal functions
Rats were kept in metabolic cages for 48 hours with free access 
to water and food and under a controlled light/dark cycle and 
temperature to collect the urine volume. Blood samples were 
obtained from rats by cardiac puncture prior to sacrifice. 
Creatinine and urea plasma concentrations were assessed 
using a commercial kit (Wiener Lab, Rosario, Argentina). 
Proteinuria (pyrogallol red-molybdate [colorimetric], 
Alcyon 300I analyzer, Abbott Laboratories, Chicago, IL) 
and microalbuminuria (nephelometry IMMAGE,   Beckman 
Coulter, Brea, CA) were also measured.
Light microscopy
Rats were anesthetized (100 µg ketamine and 10 µg 
diazepam/g body weight, intraperitoneally) and perfused 
with 4% paraformaldehyde in phosphate-buffered saline 
(PBS). Kidneys were removed and tissues were fixed in 
  formol buffer 10% in PBS 0.1 M (pH 7.4). The tissue   sections 
were dehydrated and included in paraffin. Sagittal cuts 
(5 µm) were made with a microtome (Leica RM 2125; Leica 
Gmbh, Wetzlar, Germany) and mounted on 2% silane-coated 
slides. The slides were stained with hematoxylin-eosin and 
observed by light microscopy (Nikon Eclipse 200; Nikon, 
Tokyo, Japan).
Immunofluorescence
The slides were preincubated with no immune rabbit serum 
in PBS (1:50) at room temperature for 30 minutes, followed 
by incubation with a polyclonal anti-nephrin or polyclonal 
anti-PC (1:50, Alpha Diagnostic, San Antonio, TX) and poly-
clonal anti-megalin (1:50, Santa Cruz Biotechnology, Santa 
Cruz, CA) antibodies overnight in a wet chamber at 4°C. 
After several rinses in PBS, the slides were incubated with an 
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anti-rabbit IgG antibody conjugated with fluorescein (1:200, 
Santa Cruz Biotechnology) for 1 hour at room temperature 
in a wet chamber. Finally, all the slides were mounted on 
a mixture containing PBS:glycerol (1:3), and observed in 
an epifluorescent microscope (Nikon Eclipse E200, Nikon, 
Tokyo, Japan). Negative controls were performed without 
primary antibodies.
Immunoperoxidase
Samples were blocked with endogenous peroxidase with 
H2O2 0.3% for 10 minutes. Later, the slides were preincubated 
with no immune rabbit serum, diluted in PBS (1:50) at room 
temperature for 30 minutes and incubated with the primary 
antibodies: anti-megalin (1:50, Santa Cruz Biotechnology) 
or anti-TGF-β1 (1:100, Santa Cruz Biotechnology) in a 
humidity chamber at 4°C overnight. The immunoperoxidase 
technique was then performed following the protocol from 
the RTU Vectastain Kit (Vector, Peterborough, UK). The 
antigen was revealed by diaminobenzidine (DAB, Vector). 
Finally, the sections were counterstained and mounted for 
observation. Negative controls were performed without 
primary antibodies.
Measurement of nephrin, PC, and megalin 
expressions
Ten separate fields of each section stained by immunofluo-
rescence using nephrin and PC antibodies and immunohis-
tochemistry using anti-megalin antibody were scanned at 
200× magnification, put into digital form and analyzed using 
imaging software (Image Pro Plus 5.1 Media Cybernetics, 
Silver Spring, MD).
Western Blot
The renal cortex was micro-dissected and homogenized in 
buffer (10 mM triethanolamine, 250 mM sucrose, pH 7.6) with 
proteinase inhibitors. The protein concentration was deter-
mined with the BCA Protein Assay Kit (Pierce Biotechnology 
Inc, Rockford, IL). Samples of 100 µg were electrophoresed 
using 12.5% gels and electroblotted. Blots were incubated 
with rabbit polyclonal anti-nephrin or anti-PC antibodies 
(1:1000) and horseradish peroxidase-conjugated goat anti-
rabbit IgG antibody (1:3000, Bio-Rad, Hercules, CA).
To determine the uniformity of loading, protein blots 
were probed with monoclonal anti-β-actin antibody (1:1000, 
Sigma-Aldrich, St Louis, MO). Band intensities were mea-
sured using Quantity One densitometry software package 
(Bio-Rad). Protein bands were normalized to their respective 
β-actin bands. The immunoblot analysis was carried out on 
three different tissue preparations from three independent 
experiments.
Statistical analysis
Data shown are mean ± SEM. The statistical significance 
between two mean values obtained for two different experi-
mental conditions was calculated using Student’s t-test. 
A value of P , 0.05 was considered significant. Statistical 
analysis was performed using GraphPad InStat (v 3.6; 
GraphPad Software, Inc, La Jolla, CA).
Results
A significant increase in creatinine (1.8 ±  0.3  vs 
0.35 ± 0.2 mg/dL, P , 0. 01, n = 12) and urea (263 ± 8.1 vs 
7.9 ± 6.8 mg/dL, P , 0.01, n = 12) plasma concentrations 
was observed in experimental rats at 48 hours post-sStx2 
treatment as compared with control rats. No changes were 
detected in the urine volume of the two groups of rats 
(16.7 ± 3 vs 21.3 ± 2 mL/d, n = 12). Detection of proteinuria 
and microalbuminuria 48 hours after Stx2 treatment in the 
urine collected for 24 hours in metabolic cages showed a 
significant increase in microalbuminuria (1.40 ± 0.32 vs 
0.60 ± 0.10, P , 0.01, n = 12) without changes in the pro-
teinuria values with respect to the control rats (Table 1).
The hematoxylin-eosin stain showed tubular necrosis and 
mesangiolysis (Figure 1B).
Using immunoperoxidase studies, renal tubules 
showed increased expression of TGF-β1 in the basolateral 
membrane and cytoplasm as well as in the podocytes and 
glomerular mesangium from sStx2-treated rats at 48 hours 
(Figure 2A and C).
Table 1 Renal functions at 48 hours post-treatment
N = 6 per group,  
48 hours
Control rats sStx2-treated   
rats
Proteinuria 
(mg/dL)
26 ± 10 40 ± 14
Microalbuminuria 
(mg/dL)
0.64 ± 0.33 1.32 ± 0.37*
Plasma creatinine  
(mg/dL)
0.34 ± 0.3 1.5 ± 0.2*
Plasma urea 
(mg/dL)
7.5 ± 6.1 252 ± 7.3*
Urine volume 
(mL/d)
16.8 ± 4 20.3 ± 3
Notes: *P , 0.01 control versus experimental group. sStx2-treated rats developed 
an  increase  in  plasma  creatinine  and  urea  concentrations.  Urine  microalbumin 
concentration also showed an increase without changes in the proteinuria values. 
Urine volume showed no differences when compared with controls. sStx2-treated 
rats showed a decrease in their body weight.
Abbreviation: sStx2, supernatant Shiga toxin type 2.
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The expression of megalin in sStx2-treated rats was 
decreased by immunoperoxidase (Figure 3A and B). 
The cytoplasm showed a granular pattern of megalin expres-
sion (Figure 3C) by immunofluorescence techniques.
The number of tubules positive for megalin was counted 
and the percentage measured using a grid superimposed 
on the image. Expression of megalin (21.8% ± 4.7% vs 
94.2% ± 2.9%; P , 0.01, n = 4) was significantly decreased 
with respect to the controls (Figure 3I).
The immunofluorescence studies of glomeruli from 
sStx2-treated rats at 48 hours showed a decreased expres-
sion of   nephrin (Figure 4B) and PC in podocytes (Fig-
ure 4D).   Morphometric quantification detected a significant 
decrease in the expression of nephrin (32.16 ± 10.6 vs 
176.33 ± 16.6; P , 0.01, n = 6) and PC (19.16 ± 7.9 vs 
122.16 ± 10.6; P , 0.01, n = 6) with respect to the controls   
(Figure 4E and F).
Western blot analysis performed on the renal cortex from 
sStx2-treated and control rats using anti-nephrin and anti-PC 
antibodies confirmed the results observed by immunofluo-
rescence showing decreased expression in the 185 kDa band 
corresponding to nephrin (Figure 5A and B) and 140 kDa 
band corresponding to PC (Figure 5C and D).
Discussion
The current study demonstrates for the first time that 
the early response of podocytes to the effect of Stx2 is 
related to the decreased expression of nephrin and PC 
proteins as observed by Western blot and immunohis-
tochemistry studies. These results are associated with 
the decrease and alteration observed in the pattern of 
megalin expression in the proximal tubule. The decrease 
in megalin expression could be involved in a development 
of microalbuminuria.
AB
400× 400×
Figure 1 Histological sections from control and experimental rats. (A) Control 
rats,  (B)  sStx2-treated  rats  showing  mesangiolysis  (black  asterisk)  and  tubular 
necrosis (black arrow).
Note: Magnification at 400×.
Abbreviation: sStx2, supernatant Shiga toxin type 2.
C
A B
D
1000× 1000×
1000× 1000×
Figure 2 TGF- β1 immunodetection. (A) sStx2-treated rats showing TGF-β1 expression in the basolateral membrane (black arrow) and the cytoplasm (black arrowhead) of renal 
tubules, (B and D) control rats showed no stain for TGF-β1, (C) sStx2-treated rats showing expression in the mesangium (black arrowhead) and podocytes (black arrow).
Note: Magnification at 1000×.
Abbreviation: sStx2, supernatant Shiga toxin type 2.
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Functional studies carried out in the present work are 
in agreement with our previous findings.13 We showed that 
Stx2-treated rats developed increases in creatinine and 
urea plasma concentrations, which are markers of renal 
  dysfunction. Urine volume showed similar results.
The present study demonstrates that Stx2-treated rats develop 
microalbuminuria at 48 hours post-treatment, without changes in 
the proteinuria values. It is known that approximately 2%–4% of 
patients with HUS die during the acute phase, and that one-third 
of the 96% who survive are at risk of chronic sequelae such as 
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Figure 3 Megalin immunodetection. sStx2-treated rats showing decreased expression of megalin in proximal tubules (A and B) (black arrows), (C) (white arrow); (D–F), 
control rats; (G–I), negative controls without primary antibody; (C, F and H), immunofluorescence; (A, B, D, E, and G), immunoperoxidase. (I) the number of tubules 
positive for megalin by immunoperoxidase were counted and the percentage measured using a grid superimposed on the image. Megalin was significantly decreased with 
respect to the controls (21.8% ± 4.7% vs 94.2% ± 2.9%; P , 0.01, n = 4).
Notes: Magnification for (A, D, F, G and H) at 200×; for (B, C and E) at 400×.
Abbreviation: sStx2, supernatant Shiga toxin type 2.
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Figure 4 Nephrin and PC immunodetection. (A) nephrin expression (white arrows) in control rats; (B) sStx2-treated rats showing a decreased expression of nephrin (white 
arrowhead); (C) PC expression in control rats (white arrowhead); (D) a marked decreased expression of PC in sStx2-treated rats. The number of positive marks of nephrin 
and PC was counted in ten fields of 200× using a grid superimposed on the image. (E) Expressions of nephrin (176.33 ± 16.6 vs 32.16 ± 10.6; P , 0.01, n = 6) and (F) PC 
(122.16 ± 10.6 vs 19.16 ± 7.9; P , 0.01, n = 6) were significantly decreased with respect to the controls.
Note: Magnification for (A–D) at 200×.
Abbreviations: sStx2, supernatant Shiga toxin type 2; PC, podocalyxin.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
33
Early renal response to the effect of a Shiga toxin type 2International Journal of Nephrology and Renovascular Disease 2012:5
proteinuria.1,18   Microalbuminuria has been identified as a predic-
tor of progressive renal disease in various clinical settings.19–21
It has been described that, during HUS, renal endothelial 
and podocyte cells are very sensitive to the action of Stx222 
and that lipopolysaccharide from Escherichia coli often 
triggers albuminuria and glomerular nephritis. It has been 
found that in inflammatory diseases there is an increase in 
plasma interleukin-1β (IL-1β) and TNF-α concentrations 
related to a transient downregulation of nephrin.23
We thus suggest that this mechanism could be involved in 
the development of microalbuminuria since we have previ-
ously observed that the cytotoxic effect of Stx2 holotoxin is 
enhanced by IL-1β, TNF-α, and LPS.24
It is known that under physiological conditions the slit 
diaphragm may maintain this stability in response to changes 
in filtration pressure. This would require constant reorgani-
zation of the podocyte foot process and the slit diaphragm 
components, but the mechanisms underlying the turnover of 
slit diaphragm proteins are largely unknown. Recent studies 
have provided evidence that podocytes have a key function 
in the development of albuminuria.25,26
Abnormal uptake of plasma proteins by podocytes has 
been described as a mechanism developed after TGF-β1 
upregulation.27 In agreement with this we detected TGF-β1 
expression in podocytes and mesangium.
sStx2-treated rats showed a significantly decreased 
expression of nephrin and PC slit diaphragm proteins at 
48 hours post-sStx2 inoculation. In agreement with our 
results, Wiggins et al demonstrated that reduced   expression 
of components of the slit diaphragm, such as nephrin 
and PC, and podocyte loss are associated with proteinu-
ria and glomerulosclerosis.28 Moreover, in experimental 
models of nephrosis with proteinuria, it has been shown 
that the connection of PC to the actin cytoskeleton is   
disrupted.29,30
In studying the transport mechanism involved in protein 
reabsorption in proximal tubules, we detected a modi-
fied pattern expression of megalin and TGF-β1. Megalin 
expression was decreased whereas TGF-β1 was detected 
in the basolateral membranes and cytoplasm of proximal 
tubules from sStx2-treated rats by immunohistochemistry. 
Albumin endocytosis in a cell culture model (proximal-
tubule-derived opossum kidney [OK] cells) is mediated by 
megalin/cubulin and regulated by TGF-β1 by a downregula-
tion of the system affecting the binding, internalization, and 
intracellular trafficking of the ligand   albumin.31 Previously, 
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Figure 5 Nephrin and PC immunodetection by Western blot in renal cortex. (A) representative blots of nephrin; (C) representative blots of PC; (B and D) bar graphs 
representing average protein levels normalized to the internal control β-actin. Note that the 185 kDa band corresponding to nephrin and the 140 kDa band corresponding 
to PC were decreased in sStx2-treated rats as compared to controls.
Abbreviations: sStx2, supernatant Shiga toxin type 2; PC, podocalyxin.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
34
Ochoa et alInternational Journal of Nephrology and Renovascular Disease 2012:5
we reported the immunophenotype changes in tubular cells 
damaged by Stx2 by TGF-β1 in rats.14
We suggest that megalin deficiency is associated with 
the increased expression of TGF-β1 that produces the immu-
nophenotype change of tubular cells, and the presence of 
microalbuminuria at 48 hours post-sStx2 inoculation.
We thus suggest that the inflammatory state developed dur-
ing response to Stx2 could be related to the modifications in the 
slit diaphragm structure and in the albumin endocytosis system 
associated with an increase in the active form of TGF-β1.
Early identification of patients at risk of progressive 
nephropathy would enable health providers to intervene and 
thereby slow or halt the development of progressive renal 
insufficiency.32
Further studies are necessary to detect the intrinsic 
mechanism involved in the molecular regulation of renal 
protein management during the evolution of HUS.
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